More recently, after the molecular mechanism of the role of CD47 in the process of tumour cell escape from immune recognition was elucidated, targeting CD47 has become a novel approach for treatment and has changed the method of cancer immunotherapy. This evidence concerns the gene CD47 and neoplasm.